{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:41Z","timestamp":1782602561223,"version":"3.54.5"},"reference-count":32,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T00:00:00Z","timestamp":1125014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Local treatment with foams in patients suffering from ulcerative proctitis or proctosigmoiditis is considered a rational treatment option.<\/jats:p><jats:p><jats:bold>Aims<\/jats:bold> :\u2002To investigate colonic spread, safety, tolerability and acceptance of a newly developed budesonide foam formulation.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Twelve patients (four females, eight males) with acute proctosigmoiditis or left\u2010sided ulcerative colitis were rectally administered a single dose of [99Tcm]\u2010labelled budesonide foam (Budenofalk; Dr Falk Pharma GmbH, Freiburg, Germany) containing 2\u2003mg budesonide in 20\u2003mL foam after diagnostic colonoscopy. Thereafter, the colonic spread was assessed by means of <jats:italic>\u03b3<\/jats:italic>\u2010scintigraphy for 6\u2003h. Serum samples were taken simultaneously.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Budesonide foam spread with a maximum between 11 and 40\u2003cm, thus reaching the sigmoid colon in all patients. In some patients, the foam even extended into the distal third and the middle of the descending colon with maximum radioactivity at 4\u2003h. Systemic budesonide absorption was rapid and pharmacokinetic data were comparable with published data on marketed budesonide enemas, with mean serum <jats:italic>C<\/jats:italic><jats:sub>max<\/jats:sub> and <jats:italic>AUC<\/jats:italic><jats:sub>0\u20108h<\/jats:sub> values of 0.8\u2003\u00b1\u20030.5\u2003ng\/mL and 3.7\u2003\u00b1\u20031.9\u2003ng\u2003h\/mL, respectively. The new formulation was well accepted by all patients, who could retain the foam for at least 4\u2003h.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002In the majority of patients, budesonide foam effectively spread up to the left\u2010sided colon and thus qualifies for the local treatment of proctosigmoiditis.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02571.x","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T09:11:04Z","timestamp":1125047464000},"page":"463-470","source":"Crossref","is-referenced-by-count":37,"title":["Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis"],"prefix":"10.1111","volume":"22","author":[{"given":"M.","family":"BRUNNER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"VOGELSANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"GREINWALD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"KLETTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"KVATERNIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"SCHROLNBERGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010G.","family":"EICHLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"BRUNNER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"DUDCZAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00dcLLER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,26]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020831"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.013722"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000139178.33502.a3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6687-x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528708991947"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529108998618"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2004.08.007"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00421.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199402000-00007"},{"key":"e_1_2_6_11_2","first-page":"1345","article-title":"Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis","volume":"51","author":"Hammond A","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_12_2","first-page":"1225","article-title":"A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis","volume":"26","author":"Danielsson A","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70131-3"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02555391"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.21.10.885"},{"issue":"4","key":"e_1_2_6_16_2","first-page":"A\u2010465","article-title":"Budesonide foam vs. budesonide enema in active ulcerative colitis","volume":"126","author":"Gross V","year":"2004","journal-title":"Gastroenterology"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6499.866"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6180.1751"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(85)90092-4"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01308084"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00365.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00135-6"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(87)90621-4"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50266"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199223060-00007"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01940.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296108"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00226330"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00113.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00339.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00910.x"},{"key":"e_1_2_6_32_2","first-page":"107","volume-title":"International Falk Workshop \u2013 Glucocorticoid Therapy in Chronic Inflammatory Bowel Disease \u2013 from Basic Principles to Rational Therapy","author":"M\u00f6llmann HW","year":"1996"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01129.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02571.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02571.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:30:19Z","timestamp":1697416219000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02571.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,26]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02571.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02571.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,26]]}}}